Balchem Corporation

NasdaqGS:BCPC Stok Raporu

Piyasa değeri: US$5.2b

Balchem Yönetim

Yönetim kriter kontrolleri 4/4

Balchem CEO'su Ted Harris, Apr2015 tarihinde atandı, in görev süresi 11.08 yıldır. in toplam yıllık tazminatı $ 7.89M olup, şirket hissesi ve opsiyonları dahil olmak üzere 15.2% maaş ve 84.8% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.29% ine doğrudan sahiptir ve bu hisseler $ 15.35M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 3.8 yıl ve 8.3 yıldır.

Anahtar bilgiler

Ted Harris

İcra Kurulu Başkanı

US$7.9m

Toplam tazminat

CEO maaş yüzdesi15.18%
CEO görev süresi11.1yrs
CEO sahipliği0.3%
Yönetim ortalama görev süresi3.8yrs
Yönetim Kurulu ortalama görev süresi8.3yrs

Son yönetim güncellemeleri

Recent updates

Balchem: An Attractive Valuation Makes This Stock A Buy

Mar 27

Long-Term Nutrition And Health Trends Will Support Stronger Margins And Earnings Potential

Catalysts About Balchem Balchem supplies specialty nutrients and ingredients for human, animal and plant health, along with performance gases and related solutions. What are the underlying business or industry changes driving this perspective?

Encapsulation Investments And International Expansion Will Shape Balanced Future For Nutrition Specialist

Catalysts About Balchem Balchem produces specialty nutrition and ingredient solutions for human, animal and plant health, along with performance gases. What are the underlying business or industry changes driving this perspective?

BCPC: Dividend Increase And Buyback Program Will Support Steady Future Returns

Analysts kept their Balchem fair value estimate broadly steady at $191, pointing to only very small tweaks in assumptions such as discount rate, long term revenue growth, profit margin and future P/E as the basis for maintaining their target level. What's in the News On December 9, 2025, Balchem Corporation's Board of Directors declared an annual dividend of $0.96 per share, payable on January 20, 2026, to stockholders of record as of December 23, 2025.

If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

Feb 15
If EPS Growth Is Important To You, Balchem (NASDAQ:BCPC) Presents An Opportunity

BCPC: Share Repurchases And Higher Dividend Will Support Attractive Future Returns

Analysts have maintained their fair value estimate for Balchem at US$191. They have made only minimal adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions, indicating that their overall view on the stock's valuation drivers remains essentially unchanged.

Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?

Feb 01
Is Now An Opportune Moment To Examine Balchem Corporation (NASDAQ:BCPC)?

BCPC: Share Repurchases And Rising Dividend Will Support Attractive Future Returns

Analysts have maintained their Balchem fair value estimate at US$191, with only small tweaks to the discount rate, revenue growth, profit margin, and forward P/E assumptions. This reflects a largely unchanged view on the stock's risk and earnings profile.

BCPC: Share Repurchases And Dividend Increases Will Support Attractive Future Returns

Analysts kept their fair value estimate for Balchem steady at US$191, pointing to only very small model tweaks in the discount rate, revenue growth, margin and forward P/E assumptions rather than any change in their overall view of the company. What's in the News Balchem Corporation announced a share repurchase program authorizing the company to buy back up to 4,000,000 shares, with no expiration date on the program (Key Developments).

BCPC: Share Repurchases And Dividend Increases Will Drive Attractive Future Returns

Analysts have maintained their price target on Balchem at approximately $191.00. This reflects only marginal tweaks to underlying assumptions such as discount rate, revenue growth, and profit margin, rather than a material change in their outlook.

BCPC: Share Repurchases Will Support Attractive Long Term Return Potential

Analysts have lowered their price target on Balchem by approximately $9 to about $191 per share, reflecting more cautious assumptions around revenue growth and profit margins, even though long term valuation multiples are slightly higher. What's in the News Completed a long running share repurchase program, buying back a total of 3,475,622 shares, or about 12.76% of shares outstanding, for approximately $190.58 million since the authorization began in 1999 (Key Developments) During the most recent quarter from July 1, 2025 to September 30, 2025, repurchased 95,760 shares, roughly 0.3% of shares outstanding, for $15.42 million as the final tranche under the existing buyback plan (Key Developments) Valuation Changes The Fair Value Estimate has fallen modestly from about $200.33 to $191.00 per share, reflecting a slightly more conservative outlook.

Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital

Dec 01
Balchem (NASDAQ:BCPC) Is Experiencing Growth In Returns On Capital

Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Oct 10
Some Shareholders Feeling Restless Over Balchem Corporation's (NASDAQ:BCPC) P/E Ratio

Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Sep 26
Balchem (NASDAQ:BCPC) Could Easily Take On More Debt

Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Aug 26
Estimating The Fair Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

Jul 21
Balchem (NASDAQ:BCPC) Is Looking To Continue Growing Its Returns On Capital

These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

Jun 23
These 4 Measures Indicate That Balchem (NASDAQ:BCPC) Is Using Debt Safely

When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

May 26
When Should You Buy Balchem Corporation (NASDAQ:BCPC)?

Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

May 12
Estimating The Intrinsic Value Of Balchem Corporation (NASDAQ:BCPC)

Balchem's Q3 Shows Record Earnings And Valuation Pressure

Oct 28
User avatar

Innovating In Nutrition And Health Sectors Drives Strong Financial Growth And Market Expansion

Launch of Optifolin+ in the nutrition segment and strong Human Nutrition & Health sales indicate potential for market share expansion and sustained revenue growth.

Balchem: A Tale Of Two Businesses

May 10

Balchem: Potential Turnaround Is In The Price

Feb 21

CEO Tazminat Analizi

Ted Harris'un ücretlendirmesi Balchem'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Mar 31 2026n/an/a

US$158m

Dec 31 2025US$8mUS$1m

US$155m

Sep 30 2025n/an/a

US$149m

Jun 30 2025n/an/a

US$143m

Mar 31 2025n/an/a

US$137m

Dec 31 2024US$7mUS$1m

US$128m

Sep 30 2024n/an/a

US$122m

Jun 30 2024n/an/a

US$117m

Mar 31 2024n/an/a

US$115m

Dec 31 2023US$6mUS$1m

US$109m

Sep 30 2023n/an/a

US$103m

Jun 30 2023n/an/a

US$99m

Mar 31 2023n/an/a

US$99m

Dec 31 2022US$12mUS$1m

US$105m

Sep 30 2022n/an/a

US$109m

Jun 30 2022n/an/a

US$109m

Mar 31 2022n/an/a

US$102m

Dec 31 2021US$6mUS$1m

US$96m

Sep 30 2021n/an/a

US$93m

Jun 30 2021n/an/a

US$90m

Mar 31 2021n/an/a

US$88m

Dec 31 2020US$5mUS$1m

US$85m

Sep 30 2020n/an/a

US$83m

Jun 30 2020n/an/a

US$82m

Mar 31 2020n/an/a

US$81m

Dec 31 2019US$4mUS$915k

US$80m

Tazminat ve Piyasa: Ted 'ın toplam tazminatı ($USD 7.89M ) US pazarındaki benzer büyüklükteki şirketler için ortalamadır ($USD 8.55M ).

Tazminat ve Kazançlar: Ted 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Ted Harris (60 yo)

11.1yrs
Görev süresi
US$7,894,874
Tazminat

Mr. Theodore Lee Harris, also known as Ted, has been the Chief Executive Officer and President at Balchem Corporation since April 28, 2015. He serves as an Independent Director of Pentair Plc since April 3...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Theodore Harris
CEO, President & Chairman11.1yrsUS$7.89m0.29%
$ 15.4m
Carl Bengtsson
Executive VP7.3yrsUS$2.97m0.091%
$ 4.7m
Hatsuki Miyata
Executive VP3.8yrsUS$2.39m0.016%
$ 810.4k
M. Tignor
Senior VP & Chief Human Resources Officer4.3yrsUS$1.78m0.038%
$ 2.0m
Frederic Boned
Senior VP3.5yrsUS$2.25m0.012%
$ 647.9k
Erin Gilson
VP & Chief Accounting Officerless than a yearVeri yok0.0078%
$ 404.2k
Martin Reid
Senior VP & Chief Supply Chain Officer5.3yrsUS$1.49m0.025%
$ 1.3m
Job L. Gunsteren
Senior VP & GM of Specialty Products3.7yrsVeri yokVeri yok
George Graham
Senior VP and Chief R&D Officerless than a yearVeri yok0.010%
$ 523.4k
3.8yrs
Ortalama Görev Süresi
48.5yo
Ortalama Yaş

Deneyimli Yönetim: BCPC 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 3.8 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Theodore Harris
CEO, President & Chairman11.1yrsUS$7.89m0.29%
$ 15.4m
Daniel Knutson
Independent Director8.3yrsUS$251.00k0.014%
$ 733.3k
David Fischer
Independent Director15.7yrsUS$231.00k0.028%
$ 1.4m
Matthew Wineinger
Lead Independent Director10.7yrsUS$271.00k0.025%
$ 1.3m
Olivier Rigaud
Independent Director2.7yrsUS$231.00k0.0075%
$ 388.5k
Kathleen Fish
Independent Director4.9yrsUS$246.00k0.011%
$ 557.8k
Monica Vicente
Independent Director2.7yrsUS$231.00k0.0075%
$ 388.5k
8.3yrs
Ortalama Görev Süresi
61yo
Ortalama Yaş

Deneyimli Yönetim Kurulu: BCPC 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.3 yıldır).


Şirket Analizi ve Finansal Veri Durumu

VeriSon Güncelleme (UTC saati)
Şirket Analizi2026/05/05 05:33
Gün Sonu Hisse Fiyatı2026/05/05 00:00
Kazançlar2026/03/31
Yıllık Kazançlar2025/12/31

Veri Kaynakları

Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.

PaketVeriZaman ÇerçevesiÖrnek ABD Kaynağı *
Şirket Finansalları10 yıl
  • Gelir tablosu
  • Nakit akış tablosu
  • Bilanço
Analist Konsensüs Tahminleri+3 yıl
  • Finansal tahminler
  • Analist fiyat hedefleri
Piyasa Fiyatları30 yıl
  • Hisse senedi fiyatları
  • Temettüler, Bölünmeler ve Eylemler
Sahiplik10 yıl
  • En büyük hissedarlar
  • İçeriden öğrenenlerin ticareti
Yönetim10 yıl
  • Liderlik ekibi
  • Yönetim Kurulu
Önemli Gelişmeler10 yıl
  • Şirket duyuruları

* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.

Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.

Analiz Modeli ve Kar Tanesi

Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına GitHub sayfamızdan ulaşabilirsiniz, ayrıca raporlarımızı nasıl kullanacağınızı anlatan kılavuzlarımız ve Youtube'da eğitim videolarımız da bulunmaktadır.

Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.

Endüstri ve Sektör Metrikleri

Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.

Analist Kaynakları

Balchem Corporation 9 Bu analistlerden 4, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.

AnalistKurum
Robert LabickCJS Securities, Inc.
Timothy RameyD.A. Davidson & Co.
Raghuram SelvarajuH.C. Wainwright & Co.